Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (8)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (307)
2016 (37)
2015 (52)
2014 (32)

Results for "[search-keyword]"

Search

Sponsor content

1431 result(s) found, displaying 621 to 630

TERRY WHITE CHEMISTS RAMIPRIL ramipril 5 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

16 May 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART OMEPRAZOLE omeprazole 20 mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 April 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART OMEPRAZOLE omeprazole 20 mg enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

16 April 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS OMEPRAZOLE omeprazole 20 mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 April 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS OMEPRAZOLE omeprazole 20 mg enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

16 April 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-GEFITINIB, GEFITINIB APOTEX (Apotex Pty Ltd)

6 February 2019

Prescription medicine registration

Active ingredients: gefitinib.
TERIFLUNOMIDE-AX, TERIFLUNOMIDE APOTEX (Apotex Pty Ltd)

1 February 2019

Prescription medicine registration

Active ingredients: teriflunomide.
GTA-ONDANSETRON, PTIN-ONDANSETRON, Ipca-ONDANSETRON, ONDANSETRON APOTEX, TN-ONDANSETRON, PIP-ONDANSETRON (Apotex Pty Ltd)

14 January 2019

Prescription medicine registration

Active ingredients: ondansetron hydrochloride dihydrate.
APO-PALONOSETRON palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial (246564)

13 May 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for APO-PALONOSETRON palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial.
GenRx PALONOSETRON palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial (246562)

13 May 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for GenRx PALONOSETRON palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial.

Pages

First page
Previous page
…
Page 59
Page 60
Page 61
Page 62
Current page 63
Page 64
Page 65
Page 66
Page 67
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.